🔗 Visit the ClinicalTrials.gov page for NCT01307618
| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | Trial Watch: Immunostimulatory cytokines. | Oncoimmunology | 2012 | 1.19 |
| 2 | Trial watch: Peptide vaccines in cancer therapy. | Oncoimmunology | 2012 | 1.17 |
| 3 | Trial Watch: Peptide-based anticancer vaccines. | Oncoimmunology | 2015 | 1.13 |
| 4 | Rational combinations of immunotherapeutics that target discrete pathways. | J Immunother Cancer | 2013 | 0.95 |
| 5 | Immune checkpoint blockade in cancer treatment: a double-edged sword cross-targeting the host as an "innocent bystander". | Toxins (Basel) | 2014 | 0.92 |
| 6 | Antigen-specific vaccines for cancer treatment. | Hum Vaccin Immunother | 2014 | 0.89 |
| 7 | The pro-metastatic role of bone marrow-derived cells: a focus on MSCs and regulatory T cells. | EMBO Rep | 2012 | 0.87 |
| 8 | Adjuvants and myeloid-derived suppressor cells: enemies or allies in therapeutic cancer vaccination. | Hum Vaccin Immunother | 2014 | 0.81 |